Sequent Scientific Ltd. Fundamental & Technical Research, Share Price Today

NSE : SEQUENT
NIFTY : Nifty Microcap 250
NIFTY SECTOR : Nifty MidSmall Healthcare

About Company

SeQuent is looking towards the future with courage and confidence, because of the critical role it can play to help make a difference in global economic progress and social wellbeing. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (API and formulation). The company branded its Animal Health business as Alivira Animal Health with a singular focus to create value in the global animal health space. It caters to unaddressed global market requirements and focus on products for livestock, poultry and companion animals.

Market Cap. ₹3,171 Cr.

52 Week - High/Low ₹241/92

P/E Ratio 207.67

P/B Ratio 2.92

Enterprise Value ₹3,160 Cr.

ROE % 0.06

RSI Value 36.59

EMA 50 149.6

EMA 200 158.6

Net Profit 1 Cr.

Net Profit 3year growth -98.06 Cr.

Net Profit 3 year (back) 32 Cr.

Debt to Equity 0.05 %

EPS Growth TTM -405.0 %

Current Ratio 0.99 %

100 Day SMA 169 Rs.

200 Day SMA 167 Rs.

21 Day SMA 140 Rs.

50 Day SMA 149 Rs.

Book Value 43 Rs.

EV/EBITDA Ratio 97

QoQ EPS Growth -34 %

QoQ Operating Profit Growth -25 %

QoQ Sales Growth -14 %

Sales Latest Quarter 36 Cr.

YoY Sales Growth -14 %

Market Cap. ₹3,171 Cr.

52 Week - High/Low ₹241/92

P/E Ratio 269.53

P/B Ratio 4.83

Enterprise Value ₹3,223 Cr.

ROE % -4.85

RSI Value 36.59

EMA 50 149.6

EMA 200 158.6

Net Profit -36 Cr.

Net Profit 3year growth N/A

Net Profit 3 year (back) 95 Cr.

Debt to Equity 0.78 %

EPS Growth TTM -109.07 %

Current Ratio 1.29 %

100 Day SMA 169 Rs.

200 Day SMA 167 Rs.

21 Day SMA 140 Rs.

50 Day SMA 149 Rs.

Book Value 26 Rs.

EV/EBITDA Ratio 21

QoQ EPS Growth 31 %

QoQ Operating Profit Growth -2 %

QoQ Sales Growth 6 %

Sales Latest Quarter 391 Cr.

YoY Sales Growth 19 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages